ecteinascidin 743 has been researched along with 2,3-bis(3'-hydroxybenzyl)butyrolactone in 1 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (2,3-bis(3'-hydroxybenzyl)butyrolactone) | Trials (2,3-bis(3'-hydroxybenzyl)butyrolactone) | Recent Studies (post-2010) (2,3-bis(3'-hydroxybenzyl)butyrolactone) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 319 | 32 | 124 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Chen, H; Kossinna, P; Li, Q; Lin, C; Lin, J; Liu, GR; Liu, H; Liu, SL; Luo, Y; Wang, J; Wang, P; Wang, X; Wang, Y; Xie, K; Xu, M; Xu, X; Yang, H; Yang, J; Zeng, Z; Zhang, MC; Zhang, XH; Zhu, S | 1 |
1 other study(ies) available for ecteinascidin 743 and 2,3-bis(3'-hydroxybenzyl)butyrolactone
| Article | Year |
|---|---|
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Female; Humans; Mice; Ovarian Neoplasms; Thrombospondin 1; Trabectedin; Vascular Endothelial Growth Factor A | 2023 |